Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Ad L.M. Bakx"'
Autor:
Adam Schneeweiss, Isaac Kobrin, Ad L.M. Bakx, Joseph S. Alpert, William H. Frishman, Shimon Braun, Dan Tzivoni
Publikováno v:
The American Journal of Cardiology. 80:20C-26C
Five placebo-controlled, double-blind, multicenter, parallel-design studies were performed to evaluate the antianginal and anti-ischemic characteristics of the novel T-channel-selective calcium antagonist, mibefradil, in the treatment of patients wit
Autor:
Isaac Kobrin, Ernst E. van der Wall, Ad L.M. Bakx, Håkan Emanuelsson, Shimon Braun, Albert V.G. Bruschke
Publikováno v:
American Heart Journal. 130:748-757
Mibefradil (Ro 40-5967) is a novel calcium antagonist from a new chemical class and is the first that selectively blocks the T-type calcium channel. In this multicenter, double-blind, placebo-controlled, parallel designed study, its antianginal and a
Publikováno v:
Journal of the American College of Cardiology. 22:1016-1023
Objectives . Efficacy and safety of redilation by an autoperfusion balloon catheter over several hours were investigated in this retrospective and observational study. Background . Acute occlusion, refractory to redilation, is a serious complication
Autor:
Bakx ALM; BovenIJ Ziekenhuis, afd. Cardiologie, Amsterdam.; Contact: Ad L.M. Bakx (A.Bakx@Bovenij.nl).
Publikováno v:
Nederlands tijdschrift voor geneeskunde [Ned Tijdschr Geneeskd] 2021 Sep 16; Vol. 165. Date of Electronic Publication: 2021 Sep 16.